SCHEMBL5316760

SCHEMBL5316760

OCCCC=Cc1nn(Cc2ccc(F)cc2F)c2cc(C(F)(F)F)ccc12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNK3 O14649 2/20 0.37
ENPP2 Q13822 2/20 0.35
PTGER4 P35408 1/20 0.34
PKM P14618 1/20 0.33
PKLR P30613 1/20 0.33
NTRK1 P04629 3/20 0.33
NTRK3 Q16288 1/20 0.33
NTRK2 Q16620 1/20 0.33
PTGER1 P34995 1/20 0.33
PTGDR2 Q9Y5Y4 6/20 0.32
VNN1 O95497 1/20 0.32
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2C8 P10632 1/20 0.31
CYP2D6 P10635 1/20 0.31
CYP2A6 P11509 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2B6 P20813 1/20 0.31
CYP2C19 P33261 1/20 0.31
PTGDR Q13258 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5316757 1.00 KCNK3 (0.37) KCNK3ENPP2PTGER4PKMPKLR
SCHEMBL5317853 0.94 KCNK3 (0.38) KCNK3ENPP2PTGER4PKMPKLR
SCHEMBL5317854 0.94 KCNK3 (0.38) KCNK3ENPP2PTGER4PKMPKLR
SCHEMBL5319915 0.90 NR1H2 (0.39) ENPP2RXRANR1H2NR1H3SLC22A12
SCHEMBL5319914 0.90 NR1H2 (0.39) ENPP2RXRANR1H2NR1H3SLC22A12
SCHEMBL5317768 0.90 NR1H2 (0.40) ENPP2PTGER4PKMPKLRPTGER1
SCHEMBL5317765 0.90 NR1H2 (0.40) ENPP2PTGER4PKMPKLRPTGER1
SCHEMBL5317374 0.90 KCNK3 (0.39) KCNK3ENPP2PTGER4PKMPKLR
SCHEMBL5317372 0.90 KCNK3 (0.39) KCNK3ENPP2PTGER4PKMPKLR
SCHEMBL5349786 0.86 F2RL3 (0.42) KCNK3ENPP2PTGDR2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1786424-A2 LONIDAMINE ANALOGUES AND THEIR USE IN MALE CONTRACEPTION AND CANCER TREATMENT The University of Kansas (US) 2007-05-23 EP claimed
WO-2006023704-A2 LONIDAMINE ANALOGUES AND THEIR USE IN MALE CONTRACEPTION AND CANCER TREATMENT UNIVERSITY OF KANSAS (US) 2006-03-02 WO claimed